These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 34811872)
1. α-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson's disease. Tu HY; Yuan BS; Hou XO; Zhang XJ; Pei CS; Ma YT; Yang YP; Fan Y; Qin ZH; Liu CF; Hu LF Aging Cell; 2021 Dec; 20(12):e13522. PubMed ID: 34811872 [TBL] [Abstract][Full Text] [Related]
2. Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease. Rauschenberger L; Behnke J; Grotemeyer A; Knorr S; Volkmann J; Ip CW Neurobiol Dis; 2022 Sep; 171():105798. PubMed ID: 35750147 [TBL] [Abstract][Full Text] [Related]
3. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease. Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665 [TBL] [Abstract][Full Text] [Related]
5. Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson's disease rats. Yu L; Hu X; Xu R; Zhao Y; Xiong L; Ai J; Wang X; Chen X; Ba Y; Xing Z; Guo C; Mi S; Wu X J Ethnopharmacol; 2024 Mar; 322():117628. PubMed ID: 38158101 [TBL] [Abstract][Full Text] [Related]
6. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease. Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873 [TBL] [Abstract][Full Text] [Related]
7. Opposing effects of β-2 and β-1 adrenergic receptor signaling on neuroinflammation and dopaminergic neuron survival in α-synuclein-mediated neurotoxicity. Torrente D; Su EJ; Schielke GP; Warnock M; Mann K; Lawrence DA J Neuroinflammation; 2023 Mar; 20(1):56. PubMed ID: 36864439 [TBL] [Abstract][Full Text] [Related]
8. Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson's disease. Lv QK; Tao KX; Wang XB; Yao XY; Pang MZ; Liu JY; Wang F; Liu CF Inflamm Res; 2023 Mar; 72(3):443-462. PubMed ID: 36598534 [TBL] [Abstract][Full Text] [Related]
9. Microglia-specific knock-out of NF-κB/IKK2 increases the accumulation of misfolded α-synuclein through the inhibition of p62/sequestosome-1-dependent autophagy in the rotenone model of Parkinson's disease. Rocha SM; Kirkley KS; Chatterjee D; Aboellail TA; Smeyne RJ; Tjalkens RB Glia; 2023 Sep; 71(9):2154-2179. PubMed ID: 37199240 [TBL] [Abstract][Full Text] [Related]
10. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease. Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735 [TBL] [Abstract][Full Text] [Related]
11. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease. George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995 [TBL] [Abstract][Full Text] [Related]
12. TREM2 deficiency aggravates α-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models. Guo Y; Wei X; Yan H; Qin Y; Yan S; Liu J; Zhao Y; Jiang F; Lou H FASEB J; 2019 Nov; 33(11):12164-12174. PubMed ID: 31370707 [TBL] [Abstract][Full Text] [Related]
13. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease. Fredlund F; Jimenez-Ferrer I; Grabert K; Belfiori LF; Luk K; Swanberg M J Parkinsons Dis; 2024; 14(4):693-711. PubMed ID: 38728204 [TBL] [Abstract][Full Text] [Related]
14. A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson's disease. Lu J; Wang C; Cheng X; Wang R; Yan X; He P; Chen H; Yu Z J Neuroinflammation; 2022 May; 19(1):113. PubMed ID: 35599331 [TBL] [Abstract][Full Text] [Related]
15. Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions. Stoll AC; Kemp CJ; Patterson JR; Howe JW; Steece-Collier K; Luk KC; Sortwell CE; Benskey MJ Neurobiol Dis; 2024 Feb; 191():106411. PubMed ID: 38228253 [TBL] [Abstract][Full Text] [Related]
16. Neurodegeneration and neuroinflammation are linked, but independent of alpha-synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease. Garcia P; Jürgens-Wemheuer W; Uriarte Huarte O; Michelucci A; Masuch A; Brioschi S; Weihofen A; Koncina E; Coowar D; Heurtaux T; Glaab E; Balling R; Sousa C; Kaoma T; Nicot N; Pfander T; Schulz-Schaeffer W; Allouche A; Fischer N; Biber K; Kleine-Borgmann F; Mittelbronn M; Ostaszewski M; Schmit KJ; Buttini M Glia; 2022 May; 70(5):935-960. PubMed ID: 35092321 [TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015 [TBL] [Abstract][Full Text] [Related]